Literature DB >> 29675829

Sirolimus as a rescue therapy in children with immune thrombocytopenia refractory to mycophenolate mofetil.

Maurizio Miano1, Gioacchino Andrea Rotulo1, Elena Palmisani1, Mariateresa Giaimo1, Francesca Fioredda1, Filomena Pierri1, Agnese Pezzulla2, Maria Licciardello2, Paola Terranova1, Tiziana Lanza1, Enrico Cappelli1, Rosario Maggiore1, Michaela Calvillo1, Concetta Micalizzi1, Giovanna Russo2, Carlo Dufour1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29675829     DOI： 10.1002/ajh.25119

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis.

Authors:  Liying Peng; Chanyuan Wu; Ruping Hong; Yiduo Sun; Junyan Qian; Jiuliang Zhao; Qian Wang; Xinping Tian; Yanhong Wang; Mengtao Li; Xiaofeng Zeng
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-09-14       Impact factor: 5.346

Review 2.  The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside.

Authors:  Yimei Feng; Xiaoli Chen; Kaniel Cassady; Zhongmin Zou; Shijie Yang; Zheng Wang; Xi Zhang
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

3.  Case Report: A Novel Pathogenic Missense Mutation in FAS: A Multi-Generational Case Series of Autoimmune Lymphoproliferative Syndrome.

Authors:  Claudia L Gaefke; Jonathan Metts; Donya Imanirad; Daime Nieves; Paola Terranova; Gianluca Dell'Orso; Eleonora Gambineri; Maurizio Miano; Richard F Lockey; Jolan Eszter Walter; Emma Westermann-Clark
Journal:  Front Pediatr       Date:  2021-03-18       Impact factor: 3.418

4.  Case Report: Sirolimus Alleviates Persistent Cytopenia After CD19 CAR-T-Cell Therapy.

Authors:  Limin Xing; Yihao Wang; Hui Liu; Shan Gao; Qing Shao; Lanzhu Yue; Zhaoyun Liu; Huaquan Wang; Zonghong Shao; Rong Fu
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

Review 5.  Targeted treatment of autoimmune cytopenias in primary immunodeficiencies.

Authors:  Lucia Pacillo; Giuliana Giardino; Donato Amodio; Carmela Giancotta; Beatrice Rivalta; Gioacchino Andrea Rotulo; Emma Concetta Manno; Cristina Cifaldi; Giuseppe Palumbo; Claudio Pignata; Paolo Palma; Paolo Rossi; Andrea Finocchi; Caterina Cancrini
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

6.  Refractory immune thrombocytopenia: Lessons from immune dysregulation disorders.

Authors:  Giorgio Costagliola; Rita Consolini
Journal:  Front Med (Lausanne)       Date:  2022-09-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.